Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurosci
2005 Jan 12;252:308-17. doi: 10.1523/JNEUROSCI.3967-04.2005.
Show Gene links
Show Anatomy links
The micromolar zinc-binding domain on the NMDA receptor subunit NR2B.
Rachline J
,
Perin-Dureau F
,
Le Goff A
,
Neyton J
,
Paoletti P
.
???displayArticle.abstract???
Eukaryotic ionotropic glutamate receptor subunits possess a large N-terminal domain (NTD) distinct from the neighboring agonist-binding domain. In NMDA receptors, the NTDs of NR2A and NR2B form modulatory domains binding allosteric inhibitors. Despite a high sequence homology, these two domains have been shown to bind two ligands of strikingly different chemical nature. Whereas the NTD of NR2A binds zinc with high (nanomolar) affinity, the NTD of NR2B binds the synthetic neuroprotectant ifenprodil and its derivatives. Using both NTD-mutated/deleted receptors and isolated NTDs, we now show that the NTD of NR2B, in contrast to NR2C and NR2D, also binds zinc, but with a lower affinity. Furthermore, we present evidence that zinc and ifenprodil compete for an overlapping binding site. This modulatory binding site accounts for the submicromolar zinc inhibition of NR1/NR2B receptors. Given that zinc is accumulated and released at many glutamatergic synapses in the CNS, these findings suggest that zinc is the endogenous ligand of the NTD of both NR2A and NR2B, the two major NR2 subunits. Thus, NMDA receptors contain zinc sensors capable of detecting extracellular zinc over a wide concentration range depending on their NR2 subunit composition. The coexistence of subunit-specific zinc-binding sites of high (nanomolar) and low (micromolar) affinity on NMDA receptors raises the possibility that zinc exerts both a tonic and a phasic control of membrane excitability.
Armstrong,
Structure of a glutamate-receptor ligand-binding core in complex with kainate.
1998, Pubmed
Armstrong,
Structure of a glutamate-receptor ligand-binding core in complex with kainate.
1998,
Pubmed
Ayalon,
Functional assembly of AMPA and kainate receptors is mediated by several discrete protein-protein interactions.
2001,
Pubmed
,
Xenbase
Bogden,
Copper, zinc, magnesium, and calcium in plasma and cerebrospinal fluid of patients with neurological diseases.
1977,
Pubmed
Chen,
Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition.
1997,
Pubmed
Chen,
Functional characterization of a potassium-selective prokaryotic glutamate receptor.
1999,
Pubmed
,
Xenbase
Choi,
Identification and mechanism of action of two histidine residues underlying high-affinity Zn2+ inhibition of the NMDA receptor.
1999,
Pubmed
,
Xenbase
Christine,
Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons.
1990,
Pubmed
Coughenour,
Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
2001,
Pubmed
,
Xenbase
Cull-Candy,
NMDA receptor subunits: diversity, development and disease.
2001,
Pubmed
Fayyazuddin,
Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors.
2000,
Pubmed
,
Xenbase
Frederickson,
Importance of zinc in the central nervous system: the zinc-containing neuron.
2000,
Pubmed
Furukawa,
Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.
2003,
Pubmed
Guan,
Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide.
1992,
Pubmed
Hashimoto,
Further characterization of [3H]ifenprodil binding in rat brain.
1994,
Pubmed
Kay,
Evidence for chelatable zinc in the extracellular space of the hippocampus, but little evidence for synaptic release of Zn.
2003,
Pubmed
Kemp,
NMDA receptor pathways as drug targets.
2002,
Pubmed
Kew,
A novel mechanism of activity-dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones.
1996,
Pubmed
Kew,
An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones.
1998,
Pubmed
Legendre,
The inhibition of single N-methyl-D-aspartate-activated channels by zinc ions on cultured rat neurones.
1990,
Pubmed
Leuschner,
Subtype-specific assembly of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is mediated by their n-terminal domains.
1999,
Pubmed
Li,
Rapid translocation of Zn(2+) from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation.
2001,
Pubmed
Low,
Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors.
2000,
Pubmed
,
Xenbase
Malherbe,
Identification of critical residues in the amino terminal domain of the human NR2B subunit involved in the RO 25-6981 binding pocket.
2003,
Pubmed
,
Xenbase
Marvin,
Conversion of a maltose receptor into a zinc biosensor by computational design.
2001,
Pubmed
Mayer,
Structure and function of glutamate receptor ion channels.
2004,
Pubmed
Mayer,
Modulation of excitatory amino acid receptors by group IIB metal cations in cultured mouse hippocampal neurones.
1989,
Pubmed
Meddows,
Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors.
2001,
Pubmed
,
Xenbase
Moghaddam,
Bringing order to the glutamate chaos in schizophrenia.
2003,
Pubmed
Molnár,
Synaptically-released zinc inhibits N-methyl-D-aspartate receptor activation at recurrent mossy fiber synapses.
2001,
Pubmed
Nicolas,
Autoradiographic distribution and characteristics of high- and low-affinity polyamine-sensitive [3H]ifenprodil sites in the rat brain: possible relationship to NMDAR2B receptors and calmodulin.
1994,
Pubmed
O'Hara,
The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins.
1993,
Pubmed
Palm,
Zinc concentrations in the cerebrospinal fluid of normal adults and patients with neurological diseases.
1982,
Pubmed
Paoletti,
Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+.
1995,
Pubmed
,
Xenbase
Paoletti,
Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit.
2000,
Pubmed
,
Xenbase
Paoletti,
High-affinity zinc inhibition of NMDA NR1-NR2A receptors.
1997,
Pubmed
,
Xenbase
Perin-Dureau,
Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors.
2002,
Pubmed
,
Xenbase
Quiocho,
Atomic structure and specificity of bacterial periplasmic receptors for active transport and chemotaxis: variation of common themes.
1996,
Pubmed
Sah,
Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons.
1989,
Pubmed
Smart,
Zn2+ ions: modulators of excitatory and inhibitory synaptic activity.
2004,
Pubmed
Tamiz,
Structure-activity relationships for a series of bis(phenylalkyl)amines: potent subtype-selective inhibitors of N-methyl-D-aspartate receptors.
1998,
Pubmed
,
Xenbase
Traynelis,
Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons.
1990,
Pubmed
Traynelis,
Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit.
1998,
Pubmed
,
Xenbase
Ueno,
Mossy fiber Zn2+ spillover modulates heterosynaptic N-methyl-D-aspartate receptor activity in hippocampal CA3 circuits.
2002,
Pubmed
Vogt,
The actions of synaptically released zinc at hippocampal mossy fiber synapses.
2000,
Pubmed
Williams,
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
1993,
Pubmed
,
Xenbase
Williams,
Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors.
1996,
Pubmed
,
Xenbase
